www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/DAX-schliesst-im-Plus-Dow-Jones-34-knackt-34-13-000-Punkte-Marke-Postbank-Uebernahme-durch-Deutsche-Bank-fast-vollendet-S-P-stuft-Griechenland-ab-Bayer-Nordex-Q-Cells-im-Fokus-1687263<b>Termine vom 28.02.12:</b><br> - D: Verbraucherpreise Februar<br> - D: GfK-Konsumklimaindex Februar<br> - USA: Auftragseingang f&uuml;r langlebige G&uuml;ter Januar<br> - USA: S&P Case-Shiller HPI November<br> - USA: Verbrauchervertrauen Conference ...http://www.finanzen.net/nachricht/aktien/DAX-schliesst-im-Plus-Dow-Jones-34-knackt-34-13-000-Punkte-Marke-Postbank-Uebernahme-durch-Deutsche-Bank-fast-vollendet-S-P-stuft-Griechenland-ab-Bayer-Nordex-Q-Cells-im-Fokus-1687263http://www.finanzen.net/nachricht/Cerus-to-Present-at-Cowen-and-Company-Annual-Health-Care-Conference-750698 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that Claes Glassell, president and chief executive officer, is scheduled ...http://www.finanzen.net/nachricht/Cerus-to-Present-at-Cowen-and-Company-Annual-Health-Care-Conference-750698http://www.finanzen.net/nachricht/Cerus-Announces-Fourth-Quarter-and-Year-End-2009-Results-747007 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft4 {padding-left: 20.0px} .bwcellpaddingleft8 {padding-left: 40.0px} .bwcellpaddingright0 ...http://www.finanzen.net/nachricht/Cerus-Announces-Fourth-Quarter-and-Year-End-2009-Results-747007http://www.finanzen.net/nachricht/Data-Presented-at-International-Haemovigilance-Seminar-Confirm-Safety-of-Cerus-INTERCEPT-Blood-System-for-Platelets-and-Plasma-743938 <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that investigators from blood centers in Sweden, Belgium, France and Slovenia will present their experience with the INTERCEPT Blood System ...http://www.finanzen.net/nachricht/Data-Presented-at-International-Haemovigilance-Seminar-Confirm-Safety-of-Cerus-INTERCEPT-Blood-System-for-Platelets-and-Plasma-743938http://www.finanzen.net/nachricht/Cerus-to-Collaborate-with-French-National-Transfusion-Service-on-INTERCEPT-Red-Blood-Cell-Development-739904 <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that it has entered into a collaborative agreement with France's national transfusion service, the Etablissement Fran&ccedil;ais du Sang (EFS), ...http://www.finanzen.net/nachricht/Cerus-to-Collaborate-with-French-National-Transfusion-Service-on-INTERCEPT-Red-Blood-Cell-Development-739904http://www.finanzen.net/nachricht/Cerus-Corporation-Reports-Positive-Outcome-of-Phase-1-Clinical-Trial-of-INTERCEPT-Red-Blood-Cells-739483 <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that its Phase 1 trial of red blood cells treated with the INTERCEPT Blood System met its primary endpoint, with preliminary analysis demonstrating ...http://www.finanzen.net/nachricht/Cerus-Corporation-Reports-Positive-Outcome-of-Phase-1-Clinical-Trial-of-INTERCEPT-Red-Blood-Cells-739483http://www.finanzen.net/nachricht/Cerus-to-Release-Fourth-Quarter-and-Year-End-2009-Results-on-February-23-2010-737722 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that its fourth quarter and year-end 2009 financial results will ...http://www.finanzen.net/nachricht/Cerus-to-Release-Fourth-Quarter-and-Year-End-2009-Results-on-February-23-2010-737722http://www.finanzen.net/nachricht/Cerus-to-Present-at-12th-Annual-BIO-CEO-Investor-Conference-736183 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that Claes Glassell, President and Chief Executive Officer, is scheduled ...http://www.finanzen.net/nachricht/Cerus-to-Present-at-12th-Annual-BIO-CEO-Investor-Conference-736183http://www.finanzen.net/nachricht/Cerus-Corporation-Reports-Positive-Outcome-in-European-Study-of-7-Day-INTERCEPT-Platelets-727101 <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that INTERCEPT-treated platelet components were found to be effective for patient support following extended six and seven day storage in a ...http://www.finanzen.net/nachricht/Cerus-Corporation-Reports-Positive-Outcome-in-European-Study-of-7-Day-INTERCEPT-Platelets-727101http://www.finanzen.net/nachricht/Cerus-Corporation-Receives-FDA-Blood-Products-Advisory-Committee-Guidance-for-Proposed-INTERCEPT-Blood-System-Phase-III-Trial-Design-703121 <a href="/aktien/Cerus-Aktie">Cerus</a> Corporation (NASDAQ:CERS) announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints ...http://www.finanzen.net/nachricht/Cerus-Corporation-Receives-FDA-Blood-Products-Advisory-Committee-Guidance-for-Proposed-INTERCEPT-Blood-System-Phase-III-Trial-Design-703121